RaySearch and Philips enter license agreement for VMAT product

RaySearch and Philips enter license agreement for VMAT product

RaySearch Laboratories AB and Philips Medical Systems Inc. have signed an
extension of the existing IMRT agreement covering a new treatment planning
product for VMAT treatments. 

VMAT (Volumetric Modulated Arc Therapy) is a new advanced form of IMRT
(Intensity Modulated Radiation Therapy) where the treatment machine rotates
around the patient while the treatment beam is turned on. This concept enables
faster treatment delivery compared with traditional IMRT where the patient is
irradiated from a few selected angles. At the same time treatment quality
remains similar or can be improved compared with IMRT which is the current
golden standard.

The product will be integrated in Philps' Pinnacle3 treatment planning system
and will be marketed under the brand name SmartArc. A prototype has already been
integrated in Pinnacle3 and will be demonstrated at the major trade shows during
2008. The final product is expected to be available for clinicians during the
first half of 2009.

“The VMAT concept was recently introduced by the hardware vendors. It has
already created tremendous interest in the industry, so this product has a very
large potential for RaySearch. This is also an area that suits us exceptionally
well with our deep optimization expertise and market leading software platform.
The results I have seen so far from the current prototype are very promising
both in terms of treatment quality and delivery time as well as optimization
speed. Therefore I am convinced that SmartArc will be highly appreciated by the
Pinnacle3 users,” says Johan Löf, President of RaySearch.

FOR FURTHER INFORMATION, CONTACT:
Johan Löf, President and CEO, RaySearch Laboratories AB
Telephone: +46 (0)8-545 061 30
johan.lof@raysearchlabs.com

ABOUT RAYSEARCH
RaySearch Laboratories is a medical technology company that develops advanced
software solutions for improved radiation therapy of cancer. RaySearch's
products are sold through license agreements with leading partners such as
Philips, Varian, Nucletron, IBA Dosimetry and TomoTherapy. Eight products have
been released to date and RaySearch's software is used at over 1,300 clinics in
more than 30 countries. In addition, existing license agreements cover more than
15 other products that are scheduled to be launched in the coming years.
RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in
Stockholm and the company is listed in the SmallCap segment on the OMX Nordic
Exchange Stockholm. 

For more information about RaySearch, visit www.raysearchlabs.com.